Literature DB >> 17286792

Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.

D Li1, G-L Zhang, Y-Q Lou, Q Li, X Wang, X-Y Bu.   

Abstract

BACKGROUND AND
OBJECTIVE: The drug transporter MDR1 and the drug metabolizing enzyme CYP3A are the two major biological factors determining the pharmacokinetics of many drugs. The functional MDR1 single nucleotide polymorphisms (SNPs) and a prevalent CYP3A5 SNP show marked interethnic variation among Orientals, Caucasians and Africans. In this study, we investigated the distribution of MDR1 and CYP3A5 SNPs among mainland Chinese Han, Uygur and Kazakh ethnic groups.
METHODS: Genotypes of the MDR1 C1236T, G2677T/A and C3435T, and CYP3A5*3, CYP3AP1*3 SNPs were determined in 434 unrelated healthy subjects (165 Chinese Han, 161 Chinese Uygur and 108 Chinese Kazakh) using polymerase chain reaction followed by restriction fragment length polymorphism analysis. RESULTS AND DISCUSSION: A significantly higher MDR1 3435T variant frequency was observed in Uygur (52.8%), than in Kazakh (39.8%) and Han (37.9%) Chinese (P < 0.01, Fisher's exact test). There was no significant difference in MDR1 1236T and 2677T/A variant frequencies between Han, Uygur and Kazakh. CYP3A5*3 (G) allele was observed at intermediate frequencies in Uygur (84.8%) and Kazakh (86.6%), relative to Han (72.7%) and values previously reported in Caucasians (91.7%). The CYP3AP1*3 (A) allele was strongly linked to CYP3A5*3 in Chinese Han, Uygur and Kazakh.
CONCLUSION: Significant interethnic differences in MDR1 haplotype and CYP3A5 variant frequencies exist between mainland Chinese Han and Caucasians, and the intermediate frequencies observed in Chinese Uygur and Kazakh might be due to the genetic admixture of Eurasians and Orientals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286792     DOI: 10.1111/j.1365-2710.2007.00791.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  14 in total

1.  Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.

Authors:  Yi-xi Wang; Jia-li Li; Xue-ding Wang; Yu Zhang; Chang-xi Wang; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

2.  Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards.

Authors:  J Vicente; Blanca Sinues; A Fanlo; P Vasquez; J C Medina; B Martinez-Jarreta
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

Review 3.  A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

Authors:  King Leung Fung; Michael M Gottesman
Journal:  Biochim Biophys Acta       Date:  2009-03-11

4.  Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.

Authors:  Yixi Wang; Changxi Wang; Jiali Li; Xueding Wang; Genglong Zhu; Xiao Chen; Huichang Bi; Min Huang
Journal:  Eur J Clin Pharmacol       Date:  2008-10-21       Impact factor: 2.953

5.  ABCB1 single nucleotide polymorphisms in the Brazilian population.

Authors:  Marcos Antonio Mauricio Scheiner; Arthur Motta Damasceno; Raquel Ciuvalschi Maia
Journal:  Mol Biol Rep       Date:  2009-05-13       Impact factor: 2.316

6.  Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients.

Authors:  Xiao-Yan Qiu; Zheng Jiao; Ming Zhang; Long-Jin Zhong; Hui-Qi Liang; Chun-Lai Ma; Liang Zhang; Ming-Kang Zhong
Journal:  Eur J Clin Pharmacol       Date:  2008-07-18       Impact factor: 2.953

Review 7.  Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Authors:  Tingyu Wang; Yitian Zhou; Guosheng Cao
Journal:  Eur J Clin Pharmacol       Date:  2021-01-29       Impact factor: 2.953

Review 8.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

9.  Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients.

Authors:  Jing Liu; Zhiyu Chen; Hanmei Chen; Yingyong Hou; Weiqi Lu; Junyi He; Hanxing Tong; Yuhong Zhou; Weimin Cai
Journal:  Int J Mol Sci       Date:  2017-03-13       Impact factor: 5.923

10.  Association between Genetic Polymorphism of Multidrug Resistance 1 Gene and Sasang Constitutions.

Authors:  Hyun-Ju Kim; Seung Yeon Hwang; Ju-Ho Kim; Hye-Jung Park; Sang-Gyu Lee; Si-Woo Lee; Jong-Cheon Joo; Yun-Kyung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2009-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.